Cerebrolysin
A porcine-brain-derived mixture of peptides and amino acids, not a single sequence-defined peptide.
- Evidence grade
- CEarly Human Research
Early Human Research
- Regulatory status
- Not FDA Approved
Not FDA-approved in the United States; use or registration in another country is not US approval.
- Human data
- Yes
Registered clinical trials exist
- Last reviewed
- October 27, 2026
Overview
A porcine-brain-derived mixture of peptides and amino acids, not a single sequence-defined peptide.
Not FDA-approved in the United States; use or registration in another country is not US approval.
Regional clinical use and positive individual studies do not resolve inconsistency across controlled evidence.
Why It's Being Studied
- Stroke rehabilitation
- Neurotrophic mixtures
Mechanism of Action
Proposed neurotrophic effects concern a mixture whose components cannot be assumed to share one defined receptor mechanism.
Proposed neurotrophic effects concern a mixture whose components cannot be assumed to share one defined receptor mechanism. Regional clinical use and positive individual studies do not resolve inconsistency across controlled evidence.
From molecular target to clinical evidence
Tap each stage to see what happens.
Background: Clinical Peptide Medicines
Clinical peptide medicines include endocrine treatments, antimicrobial drugs, receptor blockers and targeted diagnostic or cancer agents. They do not share one mechanism or one set of indications.
An approval belongs to a specific medicine and indication. A diagnostic tracer, an antibiotic and a hormone are not interchangeable wellness products; read each profile's own mechanism and prescribing source.
Research Areas & Routes Studied
- Stroke rehabilitation
- Neurotrophic mixtures
- Intravenous clinical research
Evidence Summary
Human stroke trials exist. A Cochrane review found no mortality benefit and raised concern about nonfatal serious adverse events, despite positive findings in some rehabilitation studies.
Higher tiers carry more weight. Filled tiers have evidence for Cerebrolysin; tap to read it.
- Human stroke trials exist. A Cochrane review found no mortality benefit and raised concern about nonfatal serious adverse events, despite positive findings in some rehabilitation studies.
2 cited sources.
- Systematic review1
- Randomised controlled trial1
Human clinical evidence
- Human stroke trials exist. A Cochrane review found no mortality benefit and raised concern about nonfatal serious adverse events, despite positive findings in some rehabilitation studies.
Reported Adverse Events in Research
- Serious adverse events and hypersensitivity require attention; the mixture complicates component-specific attribution.
Limitations of Current Evidence
- Regional clinical use and positive individual studies do not resolve inconsistency across controlled evidence.
- Findings apply to the product, route and population studied; they do not establish benefits or safety for unrelated wellness uses or research-vial products.
How to Read This Research
- Is this a single molecule or a family of medicines?
- Is the use diagnostic, therapeutic or investigational?
- Does the quoted outcome match the exact product, formulation and population?
- Use the compound-specific mechanism above; this diagram describes drug development, not a shared biological pathway.
- Historical approval, present availability and off-label use are distinct questions.
- For radiopharmaceuticals and hospital medicines, specialist handling is part of the treatment context.
- Indication
- The condition and population for which a medicine is approved.
- Antagonist
- A compound that blocks activity at a receptor.
- Radiopharmaceutical
- A medicine containing a radioactive isotope for imaging or treatment.
Compare With Other Compounds
| Cerebrolysin | Trofinetide | |
|---|---|---|
| Evidence grade | C — Early Human Research | B — Moderate Human Evidence |
| Regulatory status | Not FDA Approved | FDA Approved for Specific Indication |
| Human data | Yes | Yes |
| Clinical trials | Registered trials exist | Registered trials exist |
| Research routes | Intravenous clinical research | Oral approved medicine |
| Cited sources | 2 | 2 |
Frequently Asked Questions
Research References
- Systematic review
Cerebrolysin — systematic review
- Randomised controlled trial
CARS stroke rehabilitation trial